Machine learning-based analysis identifies glucose metabolism-related genes ADPGK as potential diagnostic biomarkers for clear cell renal cell carcinoma

Our results suggest that targeting the glucose metabolism pathway can kill ccRCC cells. <i>ADPGK</i>, a gene related to glucose metabolism, may be an important biomarker for the diagnosis and characterization of ccRCC. However, whether <i>ADPGK</i> affects glycolysis in ccRCC, and the mechanism by which glycolysis is regulated is not clear. This is the direction of further research in the future.